PPARGC1A and metabolic dysfunction-associated steatotic liver disease: In NAFLD, high-fat diet exposure leads to the persistent acetylation of PGC-1α, reducing its activity and impairing fatty acid oxidation, promoting lipid accumulation in hepatocytes.